We work on generalizable tools for the next era of biotech.
Anthrogen is engineering post-modality biology.
Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the experimental infrastructure to instantiate them.
Hiring by function
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Generative AI for protein design
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Enzyme design models.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Making chemicals 100,000x faster
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026
What they do:
Agentic AI platform for Pharma GTM teams
Quick facts:
HQ: San Francisco, CA, United States
We work on generalizable tools for the next era of biotech.
San Francisco, CA, United States
15 employees, according to the company profile.
There are no funding rounds for Anthrogen in our data.
Yes: 8 open roles on the company’s job board.
Similar startups: Numerion Labs, Diffuse Bio, and Ligo Biosciences.